Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Dayami Lopez"'
Publikováno v:
Journal of Lipid Research, Vol 39, Iss 1, Pp 75-84 (1998)
The effects of atorvastatin on the expression of the hepatic HMG-CoA reductase and LDL receptor genes were investigated in rats. Like the other statins, atorvastatin increased the rate of degradation and presumably cycling of the hepatic LDL receptor
Externí odkaz:
https://doaj.org/article/eaa3433f1e3e48a4adf460d17724915b
Publikováno v:
Cancer Research. 83:1592-1592
Despite the significant advancements in breast cancer (BCa) research and potential therapeutic targets, mortality rates for African American (AA) women remain high compared to other ethnic groups. In the United States, BCa is the second leading cause
Autor:
Kenisha Webb, Ariel Williams, Quantil Melendez, Catherine Wooten, Natasha Greene, Dayami Lopez, Kevin Kimbro
Publikováno v:
Journal of the Endocrine Society. 6:A407-A408
Background Type 2 Diabetes (T2D) has been considered an inflammatory disease that correlates with elevated responses cytokines. The increasing prevalence of T2D worldwide, is accompanied by the higher incidence of T2D globally and nationally. African
Autor:
Dayami Lopez, Quantil M. Melendez, Catherine J. Wooten, Sreevidhya Krishnaji, David R. Kirchner, Kevin J. Knagge
Publikováno v:
International journal of biomedical investigation
High levels of cholesterol, especially as low-density lipoprotein (LDL), are a well-known risk factor for atherosclerotic-related diseases. The key atherogenic property of LDL is its ability to form atherosclerotic plaque. Proprotein convertase subti
Autor:
Dayami Lopez, Catherine J. Wooten
Publikováno v:
International Journal of Biomedical Investigation. 2:1-14
The majority of the low-density lipoprotein (LDL) receptors present in the body are expressed in the liver. Therefore, plasma LDL levels significantly correlate with changes in the activity of the hepatic LDL receptor. Based on this, there is a need
Autor:
Catherine J, Wooten, Dayami, Lopez
Publikováno v:
International journal of biomedical investigation
The majority of the low-density lipoprotein (LDL) receptors present in the body are expressed in the liver. Therefore, plasma LDL levels significantly correlate with changes in the activity of the hepatic LDL receptor. Based on this, there is a need
Autor:
Sumaira Ahmed, Quantil Melendez, Ariel Williams, Catherine Wooten, Dayami Lopez, Kevin S. Kimbro
Publikováno v:
Journal of the Endocrine Society
Heart disease is the principal cause of death and disability for both men and women in the US, accounting for 40% of all annual deaths. African American populations are disproportionately burdened with metabolic diseases, due in part to cholesterol m
Publikováno v:
Archives of Biochemistry and Biophysics. :39-53
Heart disease ends the life of more people than any other disease in the United States. High levels of low density lipoprotein (LDL)-cholesterol cause heart diseases by increasing the formation of atherosclerotic plaques. Proprotein convertase subtil
Publikováno v:
International journal of biomedical investigation
Proprotein convertase subtilisin-kexin 9 (PCSK9) appears to be involved in multiple processes. A ProtoArray Human Protein Microarray was used to identify proteins interacting with biotinylated PCSK9. Fifteen novel proteins interacting with PCSK9 were
Publikováno v:
Journal of the Endocrine Society
Hypercholesterolemia is a cardio-metabolic disease caused by a disruption in low density lipoprotein (LDL) cholesterol metabolism. Proprotein convertase subtilisin-kexin 9 (PCSK9) is an indirect regulator of plasma LDL levels by controlling the numbe